Metnizid P Cream
By Metnizid P
15gm Cream in a Tube

Composition
Metronidazole(2% w/w) + Povidone Iodine(10% w/w)

Manufacturer - Leeford Healthcare Ltd
Leeford Healthcare Limited , Leo House, Shaheed Bhagat Singh Nagar, Dugri-Dhandra Road, Near Joseph School , Ludhiana-141116

Expires on or after
July, 2026

liver
No interaction has been found or established between Metnizid P Cream and the liver. It is important to always use caution when applying any medication, especially if you have existing liver issues. Consulting with your doctor before using Metnizid P Cream is recommended to ensure proper guidance and safety.

kidney
It's important to note that no interactions have been found with regards to kidney issues in relation to Metnizid P Cream. If you have specific concerns about using this product due to kidney-related conditions, consulting with your doctor beforehand is recommended.

alcohol
No interaction between alcohol and Metnizid P Cream has been found/established. However, consult your doctor for advice when consuming alcohol with the cream, especially during pregnancy.

driving
It is safe to drive while using Metnizid P Cream as no interactions or concerns about driving have been identified.

pregnancy
Metnizid P Cream may not be safe for use during pregnancy. Animal studies suggest potential harm to the developing baby. Your doctor will assess benefits and risks before prescribing. Kindly seek advice from your doctor before using.

breastfeeding
During breastfeeding, it is advisable to be cautious when using Metnizid P Cream. It is suggested to pause breastfeeding until the mother's treatment is finished and the drug is eliminated from her body. If a single dose is used, it is recommended to wait 12-24 hours before breastfeeding again.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | DERMA |
| Action Class | - |
₹60
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025
